June 13, 2006; 66 (11) Articles
Microglial activation correlates with severity in Huntington disease
A clinical and PET study
N. Pavese, A. Gerhard, Y. F. Tai, A. K. Ho, F. Turkheimer, R. A. Barker, D. J. Brooks, P. Piccini
First published June 12, 2006, DOI: https://doi.org/10.1212/01.wnl.0000222734.56412.17
N. Pavese
A. Gerhard
Y. F. Tai
A. K. Ho
F. Turkheimer
R. A. Barker
D. J. Brooks
Microglial activation correlates with severity in Huntington disease
A clinical and PET study
N. Pavese, A. Gerhard, Y. F. Tai, A. K. Ho, F. Turkheimer, R. A. Barker, D. J. Brooks, P. Piccini
Neurology Jun 2006, 66 (11) 1638-1643; DOI: 10.1212/01.wnl.0000222734.56412.17
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 66 no. 11 1638-1643
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published June 12, 2006.
Copyright & Usage:
© 2006
Author Disclosures
- N. Pavese, MD,
- A. Gerhard, MD*,
- Y. F. Tai, MRCP*,
- A. K. Ho, PhD,
- F. Turkheimer, PhD,
- R. A. Barker, PhD,
- D. J. Brooks, MD, DSc and
- P. Piccini, MD, PhD
- N. Pavese, MD,
- A. Gerhard, MD*,
- Y. F. Tai, MRCP*,
- A. K. Ho, PhD,
- F. Turkheimer, PhD,
- R. A. Barker, PhD,
- D. J. Brooks, MD, DSc and
- P. Piccini, MD, PhD
- From the MRC Clinical Sciences Centre and Division of Neuroscience (N.P., A.G., Y.F.T., F.T., D.J.B., P.P.), Faculty of Medicine, Imperial College, Hammersmith Hospital, London, and Centre for Brain Repair and Department of Neurology (A.K.H., R.A.B.), University of Cambridge, UK.
- Address correspondence and reprint requests to Dr. P. Piccini, Hammersmith Hospital, DuCane Road, Cyclotron Bldg., W12 0NN, London, UK; e-mail: paola.piccini{at}csc.mrc.ac.uk
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Clinical manifestations of intermediate allele carriers in Huntington diseaseEsther Cubo, María A. Ramos-Arroyo, Saul Martinez-Horta et al.Neurology, July 08, 2016 -
Articles
Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's diseaseD. L. Murman, B. Giordani, A. M. Mellow et al.Neurology, July 01, 1997 -
Null Hypothesis
Clinical manifestations of homozygote allele carriers in Huntington diseaseEsther Cubo, Saul-Indra Martinez-Horta, Frederic Sampedro Santalo et al.Neurology, March 13, 2019 -
Articles
Tetrabenazine as antichorea therapy in Huntington diseaseA randomized controlled trialHuntington Study Group et al.Neurology, February 13, 2006